SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 242.00 |
| Enterprise Value ($M) | 196.18 |
| Book Value ($M) | 55.04 |
| Book Value / Share | 9.00 |
| Price / Book | 4.40 |
| NCAV ($M) | 55.04 |
| NCAV / Share | 9.00 |
| Price / NCAV | 4.40 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.28 |
| Return on Assets (ROA) | -1.75 |
| Return on Equity (ROE) | -2.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.47 |
| Current Ratio | 11.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 60.29 |
| Assets | 60.29 |
| Liabilities | 5.25 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -16.16 |
| Net Income | -15.59 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -6.40 |
| Cash from Investing | -14.34 |
| Cash from Financing | 59.29 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Tang Capital Management Llc | 0.00 | -100.00 | |
| 13G/A | Ra Capital Management, L.p. | 9.90 | 21.30 | |
| 13G | Adage Capital Management, L.P. | 9.86 | ||
| 13D/A | Monopar Therapeutics | 13.40 | ||
| 13G/A | Janus Henderson Group Plc | 17.20 | 86.12 | |
| 13D/A | Tactic Pharma LLC | 19.20 | ||
| 13G | Astrazeneca Plc | 9.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,699 | 13,518 | 27.36 | |
| 1,929 | 10,404 | 18.54 | |
| 4,932 | 19,917 | 24.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MEIP – MEI Pharma, Inc. | MIRA – MIRA Pharmaceuticals, Inc. |
| MLTX – MoonLake Immunotherapeutics | MRKR – Marker Therapeutics, Inc. |
| MTEX – Mannatech, Incorporated |
Financial data and stock pages provided by
Fintel.io